Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCentaur Regulatory News (CAU)

  • There is currently no data for CAU

Trading Update

10 Oct 2024 07:00

RNS Number : 6181H
Centaur Media PLC
10 October 2024
 

Centaur Media plc

Incorporated in England and Wales

Registration number: 04948078

LEI: 2138005WK87G7DQRQI62

ISIN: GB0034291418

 

10 October 2024

Centaur Media Plc

("Centaur" or "the Company")

 

Trading Update

 

Centaur, an international provider of business intelligence, learning and specialist consultancy, provides a trading update.

 

As highlighted in the interim results in July, the marketing sector headwinds caused by macro-economic challenges have continued to drive restructurings in the marketing functions of many blue-chip customers of Xeim. This has led to the curtailment of marketing budgets and, although we have retained most of these customers, their spend has reduced. The prolonged impact of these challenges is materially reducing revenue and profit during the second half of 2024.

 

These headwinds are having a significant impact on Xeim's Econsultancy and Oystercatchers brands, and Xeim's non-strategic advertising revenue. More positively, revenue from our future growth drivers, The Lawyer, MW Mini MBA, Festival of Marketing's October event and Marketing Week's subscriptions, has continued to improve in the second half.

 

EBITDA in 2024 will decline as a result of the impact of the high operational gearing on Xeim's lower revenue and a change in revenue mix. EBITDA will also be lower than last year due to the 2024 planned £1.3m investment in product, marketing and resources set out in our BIG27 strategy. This will accelerate the growth of our strategically valuable revenue over the next three years, in particular from The Lawyer, MW Mini MBA and Marketing Week's subscriptions.

 

The Board now expects the Company to achieve revenue of at least £34m in 2024, at an adjusted EBITDA margin of approximately 15%, which is significantly below the current analyst consensus range. This revised expectation will also impact our revenue and profit expectations in 2025.

 

Outlook

We continue to review our go-to-market plans and maintain a focus on robust cost management. We retain a cautious outlook and do not anticipate that trading conditions for the affected parts of our business will improve in the near term.

 

Nonetheless, Centaur's strong balance sheet, with £9.5m of net cash at 30 September 2024, and reliable cash conversion from our strategically valuable revenue streams, means that we are well positioned to manage this uncertainty. We will also continue to invest behind our strategy, as this will generate long-term value, while maintaining our progressive dividend policy which, as previously announced, is paying an interim ordinary dividend of 0.6 pence per share later this month.

 

Enquiries

Centaur Media plc 020 7970 4000

Swag Mukerji, Chief Executive Officer

Simon Longfield, Chief Financial Officer

 

Teneo

 

Zoë Watt / Oliver Bell

07713 157561 / 07917 221748

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTUKARRSRURRUA
Date   Source Headline
22nd Nov 20161:14 pmRNSDirector/PDMR Shareholding
21st Nov 20165:26 pmRNSTransaction in Own Shares
18th Nov 20164:20 pmRNSTransaction in Own Shares
18th Nov 20167:00 amRNSTransaction in Own Shares
16th Nov 20165:48 pmRNSTransaction in Own Shares
15th Nov 20166:03 pmRNSTransaction in Own Shares
14th Nov 20167:00 amRNSTransaction in Own Shares
11th Nov 20167:00 amRNSTransaction in Own Shares
10th Nov 201612:02 pmRNSPrice Monitoring Extension
10th Nov 20167:00 amRNSTransaction in Own Shares
9th Nov 20164:40 pmRNSSecond Price Monitoring Extn
9th Nov 20164:35 pmRNSPrice Monitoring Extension
9th Nov 20167:00 amRNSTransaction in Own Shares
7th Nov 20164:32 pmRNSTransaction in Own Shares
7th Nov 201610:14 amRNSHolding(s) in Company
7th Nov 20167:00 amRNSTransaction in Own Shares
4th Nov 201611:39 amRNSHolding(s) in Company
3rd Nov 20165:25 pmRNSTransaction in Own Shares
31st Oct 20164:40 pmRNSTotal Voting Rights
26th Oct 20167:00 amRNSTrading Statement
20th Oct 20165:50 pmRNSDirector/PDMR Shareholding
20th Oct 20167:00 amRNSTransaction in Own Shares
17th Oct 20167:00 amRNSTransaction in Own Shares
14th Oct 20167:00 amRNSTransaction in Own Shares
7th Oct 20167:00 amRNSTransaction in Own Shares
6th Oct 20169:42 amRNSGrant of Award under LTIP
5th Oct 20167:00 amRNSTransaction in Own Shares
4th Oct 20164:56 pmRNSIssue of New Ordinary Shares
4th Oct 20167:00 amRNSTransaction in Own Shares
30th Sep 20165:24 pmRNSTotal Voting Rights
30th Sep 20167:00 amRNSTransaction in Own Shares
27th Sep 20167:00 amRNSGrant of awards under LTIP
27th Sep 20167:00 amRNSTransaction in Own Shares
26th Sep 20167:00 amRNSTransaction in Own Shares
23rd Sep 20164:41 pmRNSSecond Price Monitoring Extn
23rd Sep 20164:35 pmRNSPrice Monitoring Extension
23rd Sep 20167:00 amRNSTransaction in Own Shares
22nd Sep 20164:41 pmRNSSecond Price Monitoring Extn
22nd Sep 20164:35 pmRNSPrice Monitoring Extension
22nd Sep 20167:00 amRNSDirectorate Change
21st Sep 201612:09 pmRNSDirector/PDMR Shareholding
21st Sep 20167:00 amRNSAcquisition
16th Sep 20161:50 pmRNSHolding(s) in Company
14th Sep 20166:03 pmRNSTransaction in Own Shares
13th Sep 20165:43 pmRNSTransaction in Own Shares
12th Sep 20165:52 pmRNSTransaction in Own Shares
12th Sep 20163:57 pmRNSHolding(s) in Company
2nd Sep 20164:59 pmRNSTransaction in Own Shares
1st Sep 20164:51 pmRNSTransaction in Own Shares
31st Aug 20165:22 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.